Navigation Links
XELR8 Holdings Announces Record First Quarter Revenue
Date:5/1/2008

treet.com/_yahoo/video/strategysession/10414473.html?cm_ven= YAH OO&cm_cat=FREE&cm_ite=NA#10414473

There will be a conference call today at 11:30 a.m. ET with the investment community, featuring John Pougnet, Chief Executive Officer of XELR8 Holdings, Inc. Interested parties may participate in the call by dialing 877-407-8293; international callers dial 201-689-8349. In addition, the replay of the conference call will be available approximately two hours after the call has ended. The replay can be accessed at: http://www.xelr8tools.com/Media/ConfCall050108.mp3 and will be archived for 30 days.

About XELR8 Holdings, Inc.

XELR8 Holdings, Inc. is a provider of nutritional foods and beverages designed to help enhance physical health and overall performance. XELR8 has developed a comprehensive line of nutritional supplements and functional foods designed in systems that are easy to take, simple to understand, and conveniently fit within a lifestyle. These include the Company's Eat/Drink/Snack System; Peak Performance System; and its newest market entry, Bazi(TM), a powerful, concentrated, antioxidant (Vitamins A, C & E) nutritional drink packed with eight different super fruits and berries, including the Chinese jujube plus 12 vitamins and 68 minerals, providing all the daily vitamins and minerals you need in a single, convenient, one-ounce shot.

XELR8's commitment to quality, science and research has earned the Company a loyal following of over 350 world-class athletes and an elite list of endorsers, such as 3-time World Series Champion Curt Schilling, five-time Cy Young Award Winner Randy Johnson; Super Bowl Champions Mike Alstott and Lawyer Milloy; professional football star Cadillac Williams; Olympians Briana Scurry and Caroline Lalive; Stanley Cup Winner Blake Sloan; and PGA Tour Professional Tom Pernice, Jr. XELR8 products are only available through indepe
'/>"/>

SOURCE XELR8 Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. XELR8 Holdings Announces Fiscal 2007 Financial Results
2. XELR8 Holdings to Announce 2007 Third Quarter Results on Wednesday, October 31, 2007
3. NightHawk Radiology Holdings, Inc. Announces Appointment of David Engert to the Board of Directors
4. InfuSystem Holdings Appoints Two New Board Members
5. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2008 Second Quarter Earnings Webcast
6. Agreement Executed for Amneal Pharmaceuticals to Acquire the Assets of Interpharm Holdings
7. Zimmer Holdings, Inc. Reports First Quarter Financial Results
8. NightHawk Radiology Holdings, Inc. to Host Conference Call to Discuss First Quarter 2008 Earnings Results
9. Lincare Holdings Inc. Announces First Quarter 2008 Financial Results
10. Zimmer Holdings to Present at Morgan Stanley Healthcare Unplugged Conference
11. HMS Holdings Corp. Hosts First Quarter 2008 Financial Teleconference and Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...ban on the sale of the soft drinks stating that it...t days round the corner, there is// every possibil...he consumption of soft drinks has bad affects on t...those in primary sections. So we are planning to b...
...nducted an international campaign to reduce the nu...ults have proved to be very fruitful and they have...ion drive was responsible for half a billion child...lobe. The death toll, which stood at 871 000 a ye...
...ture in the hill state of Himachal Pradesh that at...on an average//, with the gender ratio falling to ...is that despite such unchecked prevalence of fetic... far. The hill state of Himachal Pradesh register...
...e been suspected to contract meningococcemia, a po...characterized by high fever// and turn out to be f...n fever is caused by the bacteria Neisseria mening... blood vessels. Most commonly, the bacteria reside...
Other Medicine News:Health News:Female Ratio Drops Alarmingly In Himachal Due To Feticides 2Health News:Delhi Faces Threat of Brain Fever 2
(Date:9/4/2008)... Updated Survival Data for Ipilimumab...swire-FirstCall/ -- Medarex, Inc.,(Nasdaq: MEDX )...ipilimumab,an investigational anti-CTLA-4 antibod...presentations at the 33rd Congress of the European...ptember 12-16, 2008 in Stockholm.,Many of the foll...
(Date:9/4/2008)... Data Announcements Remain on Schedule with Tw...ge Clinical Data Release in November 2008, BRIDGE...maceuticals,Inc., a specialty pharmaceutical comp... metabolic disease, today announced the appointmen...rd of directors., Peter Garrambone,s career inclu...
(Date:9/3/2008)... NANJING, China, Sept. 3 /PRNewswire-FirstCal...a leading manufacturer and supplier of,branded gen...ted,anti-cancer biotech product Endu (also known a...s of Endu Phase IV clinical study., At the reques...al study,to further validate the safety and therap...
(Date:9/3/2008)... September is National Vascular Diseas.../- Diffusion Pharmaceuticals,LLC, a c...zing new drugs,for the treatment of unmet medical ... patients in a Phase I/II clinical trial of its le...The trial, designated NCT00725881,on the clinicalt...
Breaking Medicine Technology:Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 2Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology 3Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4New Poll Announces Link Between Friends and Family Influence and a Healthy Lifestyle 9131 1New Poll Announces Link Between Friends and Family Influence and a Healthy Lifestyle 9131 2New Poll Announces Link Between Friends and Family Influence and a Healthy Lifestyle 9131 3Mini stress tests could help condition heart to survive major attack 9128 1Mini stress tests could help condition heart to survive major attack 9128 2WuXi PharmaTech 28NYSE 3A WX 29 Names Temporary Chairman of the Audit Committee 9125 1WuXi PharmaTech 28NYSE 3A WX 29 Names Temporary Chairman of the Audit Committee 9125 2Medical breakthrough for organ transplants and cardiovascular diseases by Flemish researchers 1787 1Medical breakthrough for organ transplants and cardiovascular diseases by Flemish researchers 1787 2
...lects Continued Growth of Eisai,s,Commitment to On...wire/ -- Eisai,announced today that several abstra...peline compounds have been accepted for,presentati...SCO),annual meeting. ASCO takes place in Chicago f...wing and diverse oncology clinical,development pro...
... Phase II data from XL999 studies,scheduled for pr...AN FRANCISCO, May 30, 2007 /PRNewswire-FirstCall/ ...linical trials of,the company,s investigational co...007 American Society of Clinical Oncology Annual,M...Chicago,Illinois. , , -- Data from the Phase I...
Other Medicine Technology:Clinical Data on Eisai's Oncology Pipeline to be Presented at ASCO,Annual Meeting 2Clinical Data on Eisai's Oncology Pipeline to be Presented at ASCO,Annual Meeting 3Clinical Data on Eisai's Oncology Pipeline to be Presented at ASCO,Annual Meeting 4Six Abstracts Featuring Exelixis Compounds Accepted At ASCO,Conference 2
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
Medicine Products: